tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Astec LifeSciences Files SEBI Demat Compliance Certificate for December Quarter

Story Highlights
  • Astec LifeSciences reported receipt of a SEBI compliance certificate for the December 2025 quarter.
  • The registrar confirmed no securities were dematerialised, with no related certificate cancellations or ownership changes.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Astec LifeSciences Files SEBI Demat Compliance Certificate for December Quarter

Claim 50% Off TipRanks Premium

The latest announcement is out from Astec Lifesciences Limited ( (IN:ASTEC) ).

Astec LifeSciences Limited has informed the Indian stock exchanges that it has received a compliance certificate from its registrar and share transfer agent, Bigshare Services Pvt. Ltd., for the quarter ended 31 December 2025, confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The registrar has certified that no securities were received for dematerialisation during the quarter, and therefore no share certificates were mutilated, cancelled or had their ownership substituted in favour of depositories, underscoring a period of no demat-related activity and reinforcing the company’s ongoing regulatory compliance in its securities handling processes.

More about Astec Lifesciences Limited

Astec LifeSciences Limited operates in the agrochemical and life sciences sector, manufacturing active ingredients and intermediates used in crop protection and related applications, serving both domestic and international markets through formulations and technical-grade products.

Average Trading Volume: 214,315

Technical Sentiment Signal: Sell

Current Market Cap: 14.25B INR

See more insights into ASTEC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1